PlasmaCure

About PlasmaCure

Plasmacure is a Dutch medical technology company focused on healing chronic wounds through the application of cold plasma. Its flagship product is the Plasmacure PAD, a CE-certified device that generates a controlled, cold atmospheric plasma applied directly to the wound via a flexible, disposable patch. Cold plasma is an ionized gas containing reactive species like oxygen and nitrogen radicals that have antimicrobial properties and can stimulate tissue regeneration. This innovative technology addresses the significant healthcare challenge posed by chronic wounds such as diabetic foot ulcers and pressure ulcers, which are often resistant to standard treatments and result in high morbidity and healthcare costs. The device is designed for safe, repeatable application in clinical settings, with treatment protocols lasting only minutes per session. Plasmacure works closely with hospitals, clinics, and wound care specialists to integrate the system into regular wound care practice, aiming to reduce healing times and lower overall treatment costs. Founded as a spin-out from academic research, the company has secured European regulatory approval and is actively scaling distribution within the EU. By combining engineering innovation with clinical collaboration, Plasmacure exemplifies the growing field of advanced wound care technologies that seek to improve patient outcomes and reduce the burden on healthcare systems.